Science Hub
Timing Algorithm
Discover why the retina follows its own biological clock — and how aligning nutrient delivery with those natural rhythms may be just as important as the ingredients themselves.
The Retina Is Not the Same All Day
Most people think of nutrition as simple replenishment — take a supplement, deliver nutrients on a fixed schedule. That model assumes the biology being addressed is relatively constant throughout the day. For most tissues that assumption is close enough to true.
For the retina it is not.
The retina is one of the most circadian-active tissues in the human body. Photoreceptor activity, retinal pigment epithelium waste clearance, immune surveillance, neurotransmitter signaling, and glial state transitions are all clock-controlled — rising, peaking, and falling on precise daily rhythms. The retinal pigment epithelium phagocytosis cycle — the process by which retinal pigment epithelium cells engulf and clear shed photoreceptor outer segments — peaks in the early morning hours and is regulated by core circadian clock genes. Immune signaling rhythms shift from inflammatory to anti-inflammatory across the waking day. Müller glia responsiveness to biological cues is not constant — it is phase-dependent.
In a circadian-active tissue the question is not only what you deliver. It is when.
Why Timing Is Part of the Mechanism
Clarida's scientific architecture rests on a specific biological insight drawn from zebrafish retinal regeneration research. In the zebrafish model the regenerative cascade does not unfold as a uniform biological response. It unfolds as a precisely timed immune sequence — an early inflammatory signal that opens a regenerative window, a mid-phase stabilization that allows Müller glia to enter a repair-permissive state, and a late-phase resolution that closes the inflammatory loop and permits reconstruction rather than chronic degeneration.
What this means for dose timing is that the relevant question is not simply whether anti-inflammatory nutrients are present — it is whether they are delivered at the right phase of the biological sequence. A nutrient that blunts early inflammatory signaling entirely may suppress a permissive biological cue rather than work with it. A nutrient that arrives only during the resolution phase misses the window when its upstream effects are most relevant. Timing is not a compliance feature. It is a signal-shaping variable.
Clarida's six-dose protocol is designed around this principle. Each dose interval is aligned with a specific phase of the day's biological architecture.
The Six-Dose Rhythm —
A Biological Alignment System
The six doses are not divided for convenience. Their timing is based on a proposed triphasic cytokine sequence.
The early doses establish the biological context for the day — a transient early inflammatory signal consistent with the permissive cues seen in zebrafish regeneration models. The middle doses maintain the signaling state long enough for a transition to occur rather than collapsing prematurely into chronic suppression. The later doses shift toward anti-inflammatory resolution — coinciding with the IL-10-dominant phase that closes the inflammatory loop and biases the retinal environment toward restoration rather than sustained injury signaling.
This is why Clarida describes itself as a protocol rather than a supplement. A supplement delivers nutrients. A protocol shapes a biological sequence.
The Delivery Architecture
That Makes It Possible
The timing logic requires a delivery system capable of executing it. Clarida's capsule architecture uses dual compartments with pH-triggered release at two distinct levels — 6.5 and 7.0 to 7.5 — creating separate release phases along the gastrointestinal tract.
Nanocarrier-bound pigments improve retinal delivery precision. Timing-preserving coatings maintain the intended circadian sequence. An AI-adjusted chronotherapy layer personalizes dose intervals to individual sleep-wake biology and can be further refined based on optical coherence tomography findings and cytokine response profiles.
This is a three-level architecture. The circadian schedule determines when biological pressure is applied. The capsule release engineering determines where and when ingredients become bioavailable. The AI personalization layer adapts both to the individual patient rather than treating all human circadian biology as identical.
What This Makes Possible
When timing, formulation, and delivery are integrated as a system the result is something genuinely different from any existing AMD supplement — a protocol designed to convert passive nutrient exposure into coordinated biological signaling aligned with the retina's own circadian architecture.
Clarida is not optimizing a supplement. It is attempting to speak the retina's own biological language — the language of phase, sequence, and timing that the zebrafish retina uses to regenerate itself after injury.
Formal outcomes studies are planned.